These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16670073)

  • 41. Standard treatment of advanced-stage diffuse large B-cell lymphoma.
    Coiffier B
    Semin Hematol; 2006 Oct; 43(4):213-20. PubMed ID: 17027655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
    Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma.
    Habermann TM; Weller EA; Morrison VA; Gascoyne RD; Cassileth PA; Cohn JB; Dakhil SR; Woda B; Fisher RI; Peterson BA; Horning SJ
    J Clin Oncol; 2006 Jul; 24(19):3121-7. PubMed ID: 16754935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA repair gene XRCC1 polymorphisms and haplotypes in diffuse large B-cell lymphoma in a Korean population.
    Kim IS; Kim DC; Kim HG; Eom HS; Kong SY; Shin HJ; Hwang SH; Lee EY; Kim S; Lee GW
    Cancer Genet Cytogenet; 2010 Jan; 196(1):31-7. PubMed ID: 19963133
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential gene expression in non-malignant tumour microenvironment is associated with outcome in follicular lymphoma patients treated with rituximab and CHOP.
    Harjunpää A; Taskinen M; Nykter M; Karjalainen-Lindsberg ML; Nyman H; Monni O; Hemmer S; Yli-Harja O; Hautaniemi S; Meri S; Leppä S
    Br J Haematol; 2006 Oct; 135(1):33-42. PubMed ID: 16925574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study.
    Rueda A; Sabin P; Rifá J; Llanos M; Gómez-Codina J; Lobo F; García R; Herrero J; Provencio M; Jara C;
    Hematol Oncol; 2008 Mar; 26(1):27-32. PubMed ID: 17868190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas.
    Ab' Saber AM; Massoni Neto LM; Bianchi CP; Ctenas BB; Parra ER; Eher EM; Pereira JC; Takagaki T; Yamaguchi NH; Capelozzi VL
    Ann Thorac Surg; 2004 Jun; 77(6):1883-90. PubMed ID: 15172229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolution of R-CHOP therapy for older patients with diffuse large B-cell lymphoma.
    Morrison VA
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1651-8. PubMed ID: 18925856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary mediastinal large B-cell lymphoma.
    Faris JE; LaCasce AS
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Non-Hodgkin lymphoma of the infratemporalis fossa: a case report].
    Boulaich M; Oujilal A; Nazih N; Filali A; Lazrak A; Kzadri M
    Rev Stomatol Chir Maxillofac; 2003 Dec; 104(6):347-51. PubMed ID: 14968099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diffuse large B-cell lymphoma primary of lung.
    Neri N; Jesús Nambo M; Avilés A
    Hematology; 2011 Mar; 16(2):110-2. PubMed ID: 21418743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic markers in diffuse large B-cell lymphoma: Keys to the underlying biology.
    Winter JN
    Curr Hematol Malig Rep; 2007 Oct; 2(4):235-41. PubMed ID: 20425375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of p53 and p21 in primary glioblastomas.
    Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
    Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study.
    Xie Y; Bulbul MA; Ji L; Inouye CM; Groshen SG; Tulpule A; O'Malley DP; Wang E; Siddiqi IN
    Am J Clin Pathol; 2014 Apr; 141(4):593-604. PubMed ID: 24619762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic and Predictive Biomarkers in Diffuse Large B-cell Lymphoma.
    Chan A; Dogan A
    Surg Pathol Clin; 2019 Sep; 12(3):699-707. PubMed ID: 31352982
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of cell cycle regulator proteins in encapsulated thymomas.
    Baldi A; Ambrogi V; Mineo D; Mellone P; Campioni M; Citro G; Mineo TC
    Clin Cancer Res; 2005 Jul; 11(14):5078-83. PubMed ID: 16033820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.